| Post | Subject | | |
|
#208
|
193.00 Game-Changer: The FDA Approved Eye Drops That
|
barnyarddog
| 12/14/21 01:42:00 AM |
|
#207
|
Please don’t invest your grandkids money here.
|
Builder
| 06/02/21 07:47:06 AM |
|
#206
|
It doesn't look to be trading?
|
Builder
| 04/06/21 01:18:02 PM |
|
#205
|
What happened here rcookr1?
|
Builder
| 03/18/21 08:59:37 PM |
|
#204
|
That's a wrap!
|
DewDiligence
| 05/08/20 04:58:23 PM |
|
#203
|
ABBV completes $65B AGN acquisition:
|
DewDiligence
| 05/08/20 04:57:14 PM |
|
#202
|
1Q20 worldwide Botox sales=$812.2M, -6% YoY, -20% QoQ*:
|
DewDiligence
| 05/08/20 03:00:30 PM |
|
#201
|
ABBV-AGN merger expected to close 5/8/20:
|
DewDiligence
| 05/06/20 12:48:14 PM |
|
#200
|
Following FTC agreement, ABBV-AGN plan May 2020
|
DewDiligence
| 03/17/20 05:31:19 PM |
|
#199
|
ABBV-AGN receive EU approval for merger—US FTC approval
|
DewDiligence
| 03/03/20 09:31:48 AM |
|
#198
|
4Q19 worldwide Botox sales=$1.020B, +8% YoY, +10% QoQ*:
|
DewDiligence
| 02/10/20 12:48:22 PM |
|
#197
|
FDA approves AGN’s Ubrelvy (ubrogepant) for acute migraine treatment:
|
DewDiligence
| 12/23/19 03:23:55 PM |
|
#196
|
3Q19 worldwide Botox sales=$928.7M, +6% YoY, -5% QoQ*:
|
DewDiligence
| 11/05/19 10:11:51 AM |
|
#195
|
2Q19 worldwide Botox sales=$974.0M, +4% YoY, +12% QoQ*:
|
DewDiligence
| 08/06/19 07:58:18 AM |
|
#194
|
agn looking to buy EYEN. still a
|
jdlamont
| 06/25/19 11:28:58 AM |
|
#193
|
LOL. These lawsuit PRs are pre-written fill-in-the-blanks forms
|
DewDiligence
| 06/25/19 11:04:08 AM |
|
#192
|
News: $AGN Allergan Merger Investigation: Halper Sadeh LLP
|
whytestocks
| 06/25/19 10:50:25 AM |
|
#191
|
ABBV-AGN CC slides:
|
DewDiligence
| 06/25/19 10:02:47 AM |
|
#190
|
News: $AGN AbbVie to Acquire Allergan in Transformative
|
whytestocks
| 06/25/19 09:50:30 AM |
|
#189
|
RF-frequency devices for aesthetic applications go back at
|
DewDiligence
| 06/24/19 02:41:34 PM |
|
#188
|
The Zeltiq device is cryogenic and seems to
|
semi_infinite
| 06/24/19 02:17:52 PM |
|
#186
|
~ 60% more effective then laser removal. Shorter
|
RichardSawars
| 05/11/19 05:06:21 PM |
|
#185
|
[OT]—I would question the business plan of any
|
DewDiligence
| 05/11/19 05:03:00 PM |
|
#184
|
In regards to AGN.. Has anyone heard of
|
RichardSawars
| 05/11/19 11:21:25 AM |
|
#183
|
AGN 1Q19 CC transcript:
|
DewDiligence
| 05/08/19 11:13:34 AM |
|
#182
|
AGN 1Q19 CC slides:
|
DewDiligence
| 05/07/19 10:49:01 AM |
|
#181
|
(From AGN’s PR)—1Q19 worldwide Botox sales=$868.4M, +6% YoY
|
DewDiligence
| 05/07/19 10:45:24 AM |
|
#180
|
AGN 1Q19 results:
|
DewDiligence
| 05/07/19 10:45:06 AM |
|
#179
|
Abicipar pegol (a/k/a DARPin) shows 8.9% ocular inflammation
|
DewDiligence
| 04/02/19 09:42:23 AM |
|
#178
|
Three phase-3 Rapastinel trials stopped for futility:
|
DewDiligence
| 03/06/19 05:56:23 PM |
|
#177
|
AGN 4Q18 CC transcript:
|
DewDiligence
| 01/30/19 09:08:49 AM |
|
#176
|
AGN 4Q18 CC slides:
|
DewDiligence
| 01/29/19 08:58:24 AM |
|
#175
|
AGN 4Q18 results:
|
DewDiligence
| 01/29/19 08:23:17 AM |
|
#174
|
News: $AGN CoolSculpting® and Sonja Morgan Partner To
|
whytestocks
| 01/15/19 12:16:24 PM |
|
#173
|
AGN -7% on permanent recall of “textured” breast
|
DewDiligence
| 12/19/18 01:55:56 PM |
|
#172
|
AGN 3Q18 CC transcript:
|
DewDiligence
| 10/30/18 02:48:41 PM |
|
#171
|
Reason for today’s selloff: #msg-144555471.
|
DewDiligence
| 10/30/18 02:47:55 PM |
|
#170
|
AGN 3Q18 results items…
|
DewDiligence
| 10/30/18 08:20:08 AM |
|
#169
|
AGN slides from AAO webcast:
|
DewDiligence
| 10/29/18 05:27:45 PM |
|
#168
|
AGN slides from Medical Aesthetics Day:
|
DewDiligence
| 09/14/18 03:14:18 PM |
|
#167
|
Re: AGN's internal long-acting toxin
|
DewDiligence
| 09/14/18 11:20:39 AM |
|
#166
|
AGN acquires (private) Bonti for $195M plus contingencies:
|
DewDiligence
| 09/14/18 10:12:43 AM |
|
#165
|
AGN receives CRL for Ulipristal treatment for uterine fibroids:
|
DewDiligence
| 08/21/18 05:56:09 PM |
|
#164
|
AGN, EDIT announce mutual opt-ins on EDIT-101: #msg-142720697.
|
DewDiligence
| 08/06/18 04:19:22 PM |
|
#163
|
More granularity of 2Q18 Botox sales: #msg-142479825.
|
DewDiligence
| 07/27/18 08:34:42 AM |
|
#162
|
Transcript of AGN 2Q18 CC:
|
DewDiligence
| 07/27/18 08:33:47 AM |
|
#161
|
AGN 2Q18 items…
|
DewDiligence
| 07/26/18 12:09:02 PM |
|
#160
|
AGN/MOLN.SW report phase-3 AMD data for Abicipar (a/k/a DARPin):
|
DewDiligence
| 07/19/18 11:17:15 AM |
|
#159
|
AGN 1Q18 CC transcript:
|
DewDiligence
| 05/01/18 02:12:35 PM |
|
#158
|
Good earnings but, we’re down.... did I miss something?
|
sjgolf1967
| 04/30/18 07:43:16 PM |
| Post | Subject | | |